Korean J Dermatol.  2004 Oct;42(10):1378-1381.

A Case of Cutaneous Sarcoidosis Treated with Thalidomide

Affiliations
  • 1Department of Dermatology, National Medical Center, Seoul, Korea. nmcderma@hanmail.net
  • 2Korean Hansen Wellfare Association, Euwang, Korea.

Abstract

A patient with cutaneous sarcoidosis was treated with thalidomide for steroid unresponsive sarcoidal granulomas of the skin. The duration of the therapy was 16 weeks, during which time, the skin lesions showed clinically and histologically improvement. The initial dosage was 50mg a day, which was increased to 100mg a day after 5 weeks. No side effect was noted. The good response of sarcoidal granulomas of the skin to thalidomide observed in this patient demonstrates the usefulness of this drug as a possible long-term monotherapeutic or steroid-sparing agent in the treatment of cutaneous sarcoidosis.

Keyword

Sarcoidosis; Thalidomide
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr